Literature DB >> 25200829

Autotransplantation of cryopreserved ovarian tissue--effective method of fertility preservation in cancer patients.

Zaynab Gamzatova1, Eduard Komlichenko, Anna Kostareva, Mikhail Galagudza, Elena Ulrikh, Tatiana Zubareva, Tatiana Sheveleva, Elena Nezhentseva, Evgenia Kalinina.   

Abstract

OBJECTIVE: To review the literature and to present the latest advances in the autotransplantation of cryopreserved ovarian tissue.
MATERIALS AND METHODS: A literature review was conducted for all relevant articles assessing the fertility preservation, ovarian tissue transplantation, standard freezing and vitrification of ovarian tissue.
RESULTS: One of the promising and effective methods for fertility preservation may be the autotransplantation of cryopreserved ovarian tissue. At present, 30 babies have been born after orthotopic autotransplantation of frozen-thawed human ovarian tissue. Restoration of ovarian activity occurs between 3.5 months and 6.5 months. The longevity of autotransplanted ovarian tissue is about 5-7 years. The follicles are similarly preserved after all freezing methods; however, the ovarian stroma is significantly better preserved after vitrification than after slow freezing. An important topic for further research is preparation of the "vascular bed", optimization of vitrification technique and the development of alternative procedures to avoid the transmission of cancer cells via ovarian tissue autotransplantation - "artificial ovary".
CONCLUSIONS: Cryopreservation of ovarian tissue has unique advantages over other strategies. This method: (1) does not delay cancer treatment; (2) is safer for hormone dependent malignancy; (3) can be done independent of menstrual cycles; (4) is the only option for prepubertal girls; (5) can restore not only fertility but endocrine function.

Entities:  

Keywords:  Chemotherapy; fertility preservation; ovarian tissue transplantation; radiotherapy; standard freezing; vitrification

Mesh:

Year:  2014        PMID: 25200829     DOI: 10.3109/09513590.2014.945789

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  7 in total

Review 1.  Ovarian tissue transport to expand access to fertility preservation: from animals to clinical practice.

Authors:  Francesca E Duncan; Mary Zelinski; Alexander H Gunn; Jennifer E Pahnke; Conor L O'Neill; Nucharin Songsasen; Ryan I Woodruff; Teresa K Woodruff
Journal:  Reproduction       Date:  2016-08-04       Impact factor: 3.906

Review 2.  New advances in ovarian autotransplantation to restore fertility in cancer patients.

Authors:  Mahmoud Salama; Teresa K Woodruff
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

Review 3.  Surveillance and Care of the Gynecologic Cancer Survivor.

Authors:  Stephanie S Faubion; Kathy L MacLaughlin; Margaret E Long; Sandhya Pruthi; Petra M Casey
Journal:  J Womens Health (Larchmt)       Date:  2015-07-24       Impact factor: 2.681

4.  Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study.

Authors:  Inge T A Peters; Erik W van Zwet; Vincent T H B M Smit; Gerrit Jan Liefers; Peter J K Kuppen; Carina G J M Hilders; J Baptist Trimbos
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

Review 5.  Current and Future Treatments for Classic Galactosemia.

Authors:  Britt Delnoy; Ana I Coelho; Maria Estela Rubio-Gozalbo
Journal:  J Pers Med       Date:  2021-01-28

Review 6.  Ovarian Tissue Cryopreservation in Children and Adolescents.

Authors:  Angeliki Arapaki; Panagiotis Christopoulos; Emmanouil Kalampokas; Olga Triantafyllidou; Alkis Matsas; Nikolaos F Vlahos
Journal:  Children (Basel)       Date:  2022-08-19

Review 7.  Methods of Ovarian Tissue Cryopreservation: Is Vitrification Superior to Slow Freezing?-Ovarian Tissue Freezing Methods.

Authors:  Marisa Kometas; Gregory M Christman; Joseph Kramer; Alice Rhoton-Vlasak
Journal:  Reprod Sci       Date:  2021-05-03       Impact factor: 3.060

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.